EMAIL THIS PAGE TO A FRIEND

International journal of oncology

Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma.


PMID 24806843

Abstract

Epithelial-mesenchymal transition (EMT) is an important process in the invasion and metastasis of human cervical carcinoma. The pro-inflammatory cytokine interleukin-6 (IL-6) has been shown as an EMT inducer in multiple carcinomas. However, whether the EMT program can be induced by IL-6 and the mechanisms underlying the IL-6-induced EMT in human cervical carcinoma remain to be determined. In this study, we show that IL-6 receptor (IL-6R) and signal transducer and activator of transcriptionxa03 (Stat3) were highly expressed in human cervical squamous cell carcinoma (CSCC) tissues, and the expression of EMT markers was reversed in well-differentiated and poorly-differentiated human CSCC. Additional experiments showed that IL-6 exposure in cervical carcinoma cell lines induced IL-6R and Stat3 expression, markedly promoted cell growth, and altered cell morphology. The treatment of cervical carcinoma cell lines with IL-6 resulted in downregulation of E-Cadherin and upregulation of Vimentin. Importantly, knockdown of Stat3 significantly reversed the IL-6-induced EMT program, suggesting that Stat3 is necessary for IL-6-induced EMT in the progression of human cervical carcinoma. Moreover, Slug, a member of the Snail family of EMT regulators, was observed to be associated with the expression of Stat3. We concluded that IL-6 plays an important role through Stat3 in the EMT induction and can be a potential therapeutic target and biomarker for human cervical carcinoma.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB2501026
Anti-TCP1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
HPA027337
Anti-TCP1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, ab1
HPA031082
Anti-TCP1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, ab2
SAB2701838
Anti-tp63 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2104972
Anti-TP63, (N-terminal) antibody produced in rabbit, affinity isolated antibody
SRP3096 IL-6 human, Animal-component free, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC), cell culture tested
I2786
Interleukin-6 human, IL-6, recombinant, expressed in E. coli, Animal Component Free
I1395
Interleukin-6 human, IL-6, recombinant, expressed in E. coli, lyophilized powder, suitable for cell culture
H7416 Interleukin-6 human, IL-6, recombinant, expressed in HEK 293 cells, HumanKine®, suitable for cell culture
WH0006950M1
Monoclonal Anti-TCP1 antibody produced in mouse, clone 2B2-D6, purified immunoglobulin, buffered aqueous solution
WH0008626M1
Monoclonal Anti-TP73L antibody produced in mouse, clone 3C2, purified immunoglobulin, buffered aqueous solution
PLA0279
Rabbit anti-TCP1 Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.